Cargando…

Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry

BACKGROUND: Saliva contains a large array of metabolites, many of which can be informative for the detection of diseases. Gas chromatography-mass spectrometry (GC-MS) is a system that has long been used for metabolite profiling owing to its sensitivity, specificity, reproducibility and synchronized...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantray, Shoborose, Sharma, Seema, Prabhat, Kanika, Nasrullah, Nazima, Gupta, Manu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106257/
https://www.ncbi.nlm.nih.gov/pubmed/35571322
http://dx.doi.org/10.4103/jomfp.jomfp_335_21
_version_ 1784708241679187968
author Tantray, Shoborose
Sharma, Seema
Prabhat, Kanika
Nasrullah, Nazima
Gupta, Manu
author_facet Tantray, Shoborose
Sharma, Seema
Prabhat, Kanika
Nasrullah, Nazima
Gupta, Manu
author_sort Tantray, Shoborose
collection PubMed
description BACKGROUND: Saliva contains a large array of metabolites, many of which can be informative for the detection of diseases. Gas chromatography-mass spectrometry (GC-MS) is a system that has long been used for metabolite profiling owing to its sensitivity, specificity, reproducibility and synchronized analysis; it has relatively broad coverage of compound classes including sugars, sugar alcohols, glycosides and lipophilic compounds. AIM AND OBJECTIVES: The present study was conducted to explore the use of GC-MS in assessing variation in salivary metabolites and to recognize the metabolites which can be used as disease diagnostic tools and metabolite markers for detection of oral squamous cell carcinoma. MATERIALS AND METHODS: The present study included clinically and histopathologically confirmed oral squamous cell carcinoma (OSCC) and oral leukoplakia patients (OLK) and the control group. Patients were divided into three groups: OSCC (n = 30), OLK (n = 30) and healthy individuals as controls (n = 30). Patients were refrained from eating, drinking, smoking or oral hygiene procedures for at least 1.5 h before the collection. Saliva was collected between 9.00 and 10.00 am. Samples were stored at −80°C. Filtered samples were used for GC-MS. RESULTS: Fifteen compounds differed significantly between control, OLK and OSCC. These metabolites were decanedioic acid, 2-methyloctacosane, eicosane, octane, 3,5-dimethyl, pentadecane, hentriacontane, 5, 5-diethylpentadecane, nonadecane, oxalic acid, 6-phenylundecanea, l-proline, 2-furancarboxamide, 2-isopropyl-5-methyl-1-heptanol, pentanoic acid, Docosane. CONCLUSION: The findings of the study suggest the application of salivary metabolomics as a promising tool in the identification of tumor-specific biomarkers in early diagnosis and prediction of OSCC and oral leukoplakia. In future, standardizing the protocol for salivary analysis and overcoming some of the limitations will be helpful to establish salivary metabolomics as a reliable, the highly sensitive and specific method for clinical use as an independent diagnostic aid.
format Online
Article
Text
id pubmed-9106257
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91062572022-05-14 Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry Tantray, Shoborose Sharma, Seema Prabhat, Kanika Nasrullah, Nazima Gupta, Manu J Oral Maxillofac Pathol Original Article BACKGROUND: Saliva contains a large array of metabolites, many of which can be informative for the detection of diseases. Gas chromatography-mass spectrometry (GC-MS) is a system that has long been used for metabolite profiling owing to its sensitivity, specificity, reproducibility and synchronized analysis; it has relatively broad coverage of compound classes including sugars, sugar alcohols, glycosides and lipophilic compounds. AIM AND OBJECTIVES: The present study was conducted to explore the use of GC-MS in assessing variation in salivary metabolites and to recognize the metabolites which can be used as disease diagnostic tools and metabolite markers for detection of oral squamous cell carcinoma. MATERIALS AND METHODS: The present study included clinically and histopathologically confirmed oral squamous cell carcinoma (OSCC) and oral leukoplakia patients (OLK) and the control group. Patients were divided into three groups: OSCC (n = 30), OLK (n = 30) and healthy individuals as controls (n = 30). Patients were refrained from eating, drinking, smoking or oral hygiene procedures for at least 1.5 h before the collection. Saliva was collected between 9.00 and 10.00 am. Samples were stored at −80°C. Filtered samples were used for GC-MS. RESULTS: Fifteen compounds differed significantly between control, OLK and OSCC. These metabolites were decanedioic acid, 2-methyloctacosane, eicosane, octane, 3,5-dimethyl, pentadecane, hentriacontane, 5, 5-diethylpentadecane, nonadecane, oxalic acid, 6-phenylundecanea, l-proline, 2-furancarboxamide, 2-isopropyl-5-methyl-1-heptanol, pentanoic acid, Docosane. CONCLUSION: The findings of the study suggest the application of salivary metabolomics as a promising tool in the identification of tumor-specific biomarkers in early diagnosis and prediction of OSCC and oral leukoplakia. In future, standardizing the protocol for salivary analysis and overcoming some of the limitations will be helpful to establish salivary metabolomics as a reliable, the highly sensitive and specific method for clinical use as an independent diagnostic aid. Wolters Kluwer - Medknow 2022 2022-03-31 /pmc/articles/PMC9106257/ /pubmed/35571322 http://dx.doi.org/10.4103/jomfp.jomfp_335_21 Text en Copyright: © 2022 Journal of Oral and Maxillofacial Pathology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Tantray, Shoborose
Sharma, Seema
Prabhat, Kanika
Nasrullah, Nazima
Gupta, Manu
Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
title Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
title_full Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
title_fullStr Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
title_full_unstemmed Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
title_short Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
title_sort salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106257/
https://www.ncbi.nlm.nih.gov/pubmed/35571322
http://dx.doi.org/10.4103/jomfp.jomfp_335_21
work_keys_str_mv AT tantrayshoborose salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry
AT sharmaseema salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry
AT prabhatkanika salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry
AT nasrullahnazima salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry
AT guptamanu salivarymetabolitesignaturesoforalcancerandleukoplakiathroughgaschromatographymassspectrometry